DR. DAVID J BOZAK D.O. NPI 1841482502

NPI Details

DR. David J Bozak, D.O. is a physical medicine rehabilitation in Altoona, PA with 20 years of experience. The provider is physical medicine and rehabilitation, also referred to as rehabilitation medicine, is the medical specialty concerned with diagnosing, evaluating, and treating patients with physical disabilities. These disabilities may arise from conditions affecting the musculoskeletal system such as neck and back pain, sports injuries, or other painful conditions affecting the limbs, such as carpal tunnel syndrome. Alternatively, the disabilities may result from neurological trauma or disease such as spinal cord injury, head injury or stroke. A physician certified in physical medicine and rehabilitation is often called a physiatrist. The primary goal of the physiatrist is to achieve maximal restoration of physical, psychological, social and vocational function through comprehensive rehabilitation. Pain management is often an important part of the role of the physiatrist. For diagnosis and evaluation, a physiatrist may include the techniques of electromyography to supplement the standard history, physical, x-ray and laboratory examinations. The physiatrist has expertise in the appropriate use of therapeutic exercise, prosthetics (artificial limbs), orthotics and mechanical and electrical devices. DR. David J Bozak, D.O. NPI is 1841482502. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

3000 FAIRWAY DRIVE
BLAIR ORTHOPEDICS
ALTOONA, PA
ZIP 16602
Phone: (814) 942-1166
Fax: (814) 942-6222

The NPI 1841482502 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, onabotulinumtoxina, 1 unit (HCPCS:J0585)
• Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg (HCPCS:J7320)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (HCPCS:J3304)
• Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg (HCPCS:J2274)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Fluoroscopic guidance for needle placement (HCPCS:77002)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection of substance into lower spine canal using imaging guidance (HCPCS:62323)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Injection of lower or sacral spine facet joint using imaging guidance, single level (HCPCS:64493)
• Injection of lower or sacral spine facet joint using imaging guidance, second level (HCPCS:64494)
• Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
• Needle measurement of electrical activity in arm or leg muscles, complete study (HCPCS:95886)
• Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance (HCPCS:27096)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection of substance into middle or upper spine canal using imaging guidance (HCPCS:62321)
• Aspiration and/or injection of fluid from small joint using ultrasound guidance (HCPCS:20604)
• Injection into tendon or ligament (HCPCS:20550)
• Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming (HCPCS:95972)
• Injection of anesthetic agent and/or steroid into other nerve or branch (HCPCS:64450)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box (HCPCS:64616)
• Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician (HCPCS:62370)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level (HCPCS:64484)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Nerve conduction, 9-10 studies (HCPCS:95911)
• Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin (HCPCS:0275T)
• Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve (HCPCS:64418)
• Injection of upper or middle spine facet joint using imaging guidance, single level (HCPCS:64490)
• Injection of upper or middle spine facet joint using imaging guidance, second level (HCPCS:64491)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64633)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64634)
• Aspiration and/or injection of fluid from medium joint using ultrasound guidance (HCPCS:20606)
• Ultrasound study of arm and leg arteries (HCPCS:93922)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Set-up and patient education for remote monitoring of therapy (HCPCS:98975)

The enumeration date for this NPI number is 8/15/2007 and was last updated on 1/25/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: